2nd Annual Oncology Japan 2011

November 9-10, Hilton Tokyo (Nishi Shinjuku)

Revitalize your R&D, sales and marketing strategies in Oncology: provide tailored cancer treatment for your patient and to boost your profits

Oncology Japan is he one and only event to focus on innovative R&D, sales and marketing strategies in the Japanese Oncology market and beyond, and in its 2nd edition it will provide you the ultimate knowledge and networking experiences. With over 250 senior-level attendees, this is by far the biggest, best and most influential Pharma Oncology event.

By attending Oncology Japan 2011, you will find the answers to your most pressing challenges in Oncology and gain invaluable knowledge including:

• Realize the true commercial potential of Personalized Medicine for your company's products
• Acknowledge the impact of generics and biosimilars in Oncology and learn how to evaluate health economics to ensure your pricing strategy is fit for the near future

• Reinvent your sales strategies to target physicians in Oncology effectively, particularly the majority from large hospitals  

• Hear how to create marketing strategies that match the market's and patient's needs based on a comparison with other Asian markets and other disease areas
• Understand how Pharma can support to provide better cancer treatment for patients with key insights from cancer specialist nurses, pharmacists and patient groups

Compact agenda. Right topics all along. Great interaction.

Bruno Rossi, Operating Officer, Strategic Planning & Business Development, Bayer Yakuhin, Ltd

Experts in Oncology are ready to share their knowlede with you

Not only key players in Oncology will attend the Oncology Japan 2011, but also we have the very best speakers in the market poised ready to discuss key challenges and opportunities.

A sample of these great speakers include:

• Jun Katsura, Director and Executive Officer, Vice President, Oncology & Anaesthesia / Critical Care, AstraZeneca K. K. (Day 1 Chairperson)
• Susumu Adachi, M.D., Senior Director, Oncology Business Unit, Eli Lilly Japan K.K. (Day 2 Chairperson)
• Mark Smith, President, Merck Serono Co. Ltd. 
• Junichi Nakamichi, Country Head, Sandoz K.K.
• Dr Stephen Uden, Head of Oncology Development, Oncology Development, Novartis Pharma K.K.
• Akio Tanaka, Vice President, Deputy General Manager of Sales Division, Chugai Pharmaceutical Co., Ltd.

Check out the full conference brochure here

The summit provided a deep understanding of what other companies are working on and patients’ needs. I gained a practical hint that can be utilized for my day-to-day work.

Kozo Fukushima, Associate Manager, Business Implementation Department, Oncology & Anaesthesia / Critical Care, AstraZeneca K.K.

• Develop key relationships with thought leaders in Oncology
• Hear fresh and innovative solutions to push your oncology strategy forward
• Gain insights from them most dynamic figures that work in Oncology

It was very useful, I was able to learn not only what top pharma companies in Oncology is thinking of to improve a patient’s cancer treatment but also from patient groups’ and academics’ point of views.

Tomoko Maeda, Global Commercial Strategy, New Product Planning, Global Development, Shionogi & Co., Ltd.

For the detailed conference program, please click here

CONTACT US:

If you are interested in getting involved, please contact us:

For attending, speaking and/or programme:

Kunie Akahoshi
Email: kakahoshi@eyeforpharma.com

For sponsoring and exhibition opportunities:

Takuya Shimada
Email: tshimada@eyeforpharma.com